Surgical Robotics Patent Landscape 2026
Surgical Robotics Patent Landscape in 2026
Surgical robotics IP is heavily concentrated: a handful of established players—led by Intuitive Surgical Operations Inc—account for a dominant share of filings, while annual volume has eased from its 2022 peak. The United States is the primary filing office, and core surgical-system claims remain the crowded centre, leaving adjacent informatics and imaging branches comparatively sparse.
Intuitive Surgical leads a highly concentrated field
Intuitive Surgical Operations Inc sits at the top of the applicant ranking, followed by Cilag GmbH International and CMR Surgical Ltd. The top five filers account for 43% of the hundred largest filers’ combined total, signalling a field where a small set of incumbents commands the majority of documented innovation.
The tier gap between Intuitive Surgical and the rest is substantial. The nearest challenger, Cilag GmbH International, holds a sizeable position, but there is a step-change drop to the third and fourth ranked applicants, CMR Surgical Ltd and Auris Health Inc. Beyond rank five, no single player approaches the scale of the top tier.
| # | Applicant | Patent records | Share |
|---|---|---|---|
| 1 | Intuitive Surgical Operations Inc | 3,951 | |
| 2 | Cilag GmbH International | 2,804 | |
| 3 | CMR Surgical Ltd | 1,599 | |
| 4 | Auris Health Inc | 1,346 | |
| 5 | Ethicon Inc | 1,152 | |
| 6 | Globus Medical Inc | 1,044 | |
| 7 | Mako Surgical Corp | 839 | |
| 8 | Mazor Robotics | 621 | |
| 9 | Shenzhen Jingfeng Medical Technology Co Ltd | 530 | |
| 10 | Shanghai MicroPort MedBot (Group) Co Ltd | 419 |
| # | Applicant | Patent records | Share |
|---|---|---|---|
| 11 | Verb Surgical Inc | 405 | |
| 12 | Medical Microinstruments Inc | 369 | |
| 13 | Wuhan United Imaging Healthcare Surgical Technology Co Ltd | 345 | |
| 14 | Cornerstone Technology (Shenzhen) Ltd | 304 | |
| 15 | Think Surgical Inc | 256 | |
| 16 | SMITH & NEPHEW INC | 224 | |
| 17 | Shenzhen Institute of Advanced Biomedical Robot Co Ltd | 215 | |
| 18 | Kawasaki Heavy Industries Ltd | 214 | |
| 19 | Johns Hopkins University | 213 | |
| 20 | Stryker Corporation | 197 |
This concentration implies that new entrants and challengers face entrenched prior art at the core of laparoscopic and robotic-arm architectures, making differentiation through adjacent technology routes—imaging, informatics, or specialised end-effectors—strategically important.
Patent records from the most recent 18–24 months are subject to publication lag and will be under-counted; the apparent low volumes for 2024–2026 should not be read as a structural shift in activity. Longer-window growth, applicant concentration, and technology-route coverage are therefore more reliable signals than the latest-year bar alone.
Filing volume peaked in 2022; core surgical claims dominate the technology mix
Two complementary views frame the field’s current state: the annual filing trend shows where momentum stands, while the IPC branch breakdown reveals where technical effort has been concentrated—and where it has not.
Annual filing trend
Filings grew steadily from 2017 through 2022, reaching a peak in 2022, then eased in 2023 and appear lower in 2024–2026. The post-2022 figures are affected by publication lag and should be interpreted cautiously; the underlying activity level for those years will be clearer once the publication pipeline clears.
↗ Hover for values · click a bar to ask EurekaTechnology composition
A61B (diagnosis and surgery) is the overwhelmingly dominant IPC class, reflecting that most filings cover surgical instruments, robotic guidance, and intraoperative tools directly. B25J (manipulators and robots) is a distant second, followed by G16H (healthcare informatics) and G06T (image data processing). The long tail of smaller branches—covering topics from AI models to wireless communications—indicates opportunistic or supporting claims rather than sustained strategic investment.
↗ Hover for values · click a bar to ask EurekaHighly cited patent families surfaced by the query
Citation-heavy patent families returned by the query. Use this section as citation context, not as a curated list of the most topic-specific patents.
Robotically-assisted surgical device, robotically-…
A robotically-assisted surgical device that assists minimally invasive robotic surgery with a surgical robot is configured to acquire volume data of a non-pneumoperitoneum state of a subject, perform a pneumoperitoneum simulation on the volume data of the non-pneumoperitoneum state to generate deformation information including movement of at least one point… (excerpt from the patent abstract)
| # | Patent | Citations |
|---|---|---|
| 1 | Method and apparatus for performing minimally inva… | 3,326 |
| 2 | Platform link wrist mechanism | 3,231 |
| 3 | Robotic apparatus | 2,657 |
| 4 | Shiftable drive interface for robotically-controll… | 2,579 |
| 5 | Image-directed robotic system for precise robotic … | 2,374 |
| 6 | Grip strength with tactile feedback for robotic su… | 2,219 |
| 7 | Firing system lockout arrangements for surgical in… | 2,210 |
| 8 | Manipulator system | 2,188 |
Ranked by total forward citations. Citation counts favour older and broadly cited patent families, and broad or adjacent patents may appear when they match the search scope. Treat this section as citation context, not as a curated list of the most topic-specific patents.
What the patent structure means for R&D investment decisions
Four structural observations—maturity, concentration, collaboration patterns, and geographic reach—provide the clearest signals for teams deciding where to compete.
Post-peak, maturing field
The lifecycle evidence classifies this field as in decline, with annual filings easing back from the 2022 peak. This is characteristic of a maturing domain where foundational platform IP is largely staked, incremental differentiation dominates new filings, and competitive advantage shifts toward portfolio breadth and freedom-to-operate. Teams entering now face densely claimed core territory.
Lifecycle: post-peakTop five hold a commanding share of the largest filers
The top five applicants account for 43% of the hundred largest filers’ combined total. Intuitive Surgical Operations Inc alone holds the largest single position. This level of concentration creates high barriers to matching incumbents on volume alone, but also signals that niche specialisation—orthopedics robotics, single-port systems, or AI-guided navigation—can still yield defensible positions.
High concentrationLimited co-filing; Verb Surgical–Auris Health is the most active pairing
The most active co-applicant relationship on record is between Verb Surgical Inc and Auris Health Inc, with 34 jointly filed patent records. Covidien LP and Digital Surgery Ltd follow with 17 co-filed records. Intuitive Surgical Operations Inc has co-filed with Siemens Healthineers and Johns Hopkins University, suggesting selective academic and industrial partnerships rather than a broad open-innovation ecosystem.
Selective collaborationUS-centric filing; Europe and PCT are secondary routes
The United States is the primary filing office by a wide margin, followed by Europe (EPO) and WIPO (PCT). Australia, the United Kingdom, and Canada represent secondary validated markets. Filing presence in India, Germany, and several other jurisdictions is relatively limited, suggesting that some regional markets may remain less contested at the patent level.
US-dominantGo beyond the landscape: Eureka’s TRIZ Solution agent breaks down an R&D problem and returns patented concept solutions, each with a technical approach and cited patent & literature evidence.
| Applicant | Collaborator | Co-filings |
|---|---|---|
| Verb Surgical Inc | Auris Health Inc | 34 |
| Covidien LP | Digital Surgery Ltd | 17 |
| Intuitive Surgical Operations Inc | Siemens Healthineers | 5 |
| Intuitive Surgical Operations Inc | Johns Hopkins University | 2 |
| Intuitive Surgical Operations Inc | THE JOHNS HOPKINS UNIV JOHNS HOPKINS TECH TRANSFER | 1 |
| Verb Surgical Inc | Verily Life Sciences LLC | 1 |
Co-filing pairs, ranked by the number of jointly-filed patent families.
Intuitive Surgical leads; Cilag GmbH is the fastest-rising major challenger
The top two players occupy distinct positions: the long-established platform incumbent versus a rapidly expanding surgical-device group. Both concentrate heavily on A61B surgical and robotic-guidance subclasses.
Intuitive Surgical Operations Inc
Ranked first with 3,951 patent records, Intuitive Surgical’s portfolio is anchored in A61B 34 (computer-aided surgery), A61B 90 (surgical accessories), and A61B 17 (surgical instruments)—the three subclasses that define robotic platform ownership. Recent filing momentum shows a ▼ –30% trend versus the prior period, consistent with the field-wide post-peak pattern and a maturing core portfolio rather than a strategic retreat.
3,951 patent recordsCilag GmbH International
Ranked second with 2,804 patent records, Cilag GmbH International is the standout momentum story: recent filings show a ▲ +116% trend versus the prior period, by far the strongest trajectory among major applicants. Its technology focus mirrors the field—A61B 34, A61B 17, and A61B 90—but the volume surge suggests an aggressive build-out of surgical system and instrument IP that could narrow the gap with Intuitive Surgical over time.
2,804 patent records| Applicant | Recent (3 yrs) | Trend |
|---|---|---|
| Intuitive Surgical Operations Inc | 379 | ▼ -30% |
| Ethicon Inc | 2 | ▼ -100% |
| CMR Surgical Ltd | 215 | ▼ -48% |
| Verb Surgical Inc | 247 | ▼ -41% |
| Cilag GmbH International | 525 | ▲ +116% |
| Globus Medical Inc | 258 | ▬ -1% |
| Mako Surgical Corp | 200 | ▼ -8% |
Under-served branches adjacent to the dominant surgical core
The IPC branches below summarise areas where patent activity is relatively sparse compared with the A61B core. These are observations of relative sparsity; each is noted here only where there is a plausible technical connection to surgical robotics and a realistic path for new filings.
G16H · Healthcare Informatics
With a comparatively modest share of records relative to the A61B dominant class, G16H covers data management, clinical decision support, and outcomes analytics in surgical workflows. As robotic platforms generate increasing intraoperative data, informatics layers that aggregate, structure, and feed that data back into procedural guidance represent a plausible and technically adjacent development direction. Entrants with software and data-infrastructure expertise may find this branch less crowded than the core hardware classes.
Search this in Eureka →G06T · Image Data Processing & Generation
G06T, covering image processing and 3D reconstruction, is present in the corpus but at a fraction of the A61B volume. Intraoperative imaging, augmented-reality overlays, and real-time tissue-segmentation algorithms for surgical robots represent concrete technical applications. Teams with computer-vision or medical-imaging backgrounds may find the patent density here lower than in robotic-arm mechanics or instrument design, with a realistic entry path through novel algorithm or training-data claims.
Search this in Eureka →How leading applicants differ by technology subclass emphasis
Strength of each leader across the main technology routes.
| Player | A61B 34 · Diagnosis & surgery | A61B 90 · Diagnosis & surgery | A61B 17 · Diagnosis & surgery | B25J 9 · Manipulators & robots | A61B 18 · Diagnosis & surgery |
|---|---|---|---|---|---|
| Intuitive Surgical Operations Inc | Strong · 2,054 | Strong · 1,126 | Strong · 1,106 | Moderate · 586 | Emerging · 183 |
| Ethicon Inc | Strong · 1,328 | Strong · 942 | Strong · 1,207 | Emerging · 70 | Moderate · 592 |
| Cilag GmbH International | Strong · 694 | Strong · 606 | Strong · 626 | Emerging · 85 | Moderate · 299 |
| Verb Surgical Inc | Strong · 879 | Moderate · 376 | Moderate · 390 | Moderate · 223 | Absent |
| Globus Medical Inc | Strong · 720 | Strong · 541 | Strong · 393 | Absent | Absent |
| CMR Surgical Ltd | Strong · 877 | Moderate · 203 | Moderate · 192 | Moderate · 226 | Emerging · 136 |
Frequently asked questions
The analysis covers 16,477 patent families in scope across the global surgical robotics domain, with filing records tracked from 2017 through 2026.
Intuitive Surgical Operations Inc leads with 3,951 patent records, followed by Cilag GmbH International with 2,804 and CMR Surgical Ltd with 1,599.
The United States is the primary filing office, followed by Europe (EPO) and WIPO (PCT). Australia, the United Kingdom, and Canada are the next most active secondary jurisdictions.
A61B (diagnosis and surgery) is the dominant class by a wide margin, covering surgical instruments, robotic guidance, and intraoperative tools. B25J (manipulators and robots) is the next largest distinct class.
The field is classified as post-peak: annual filings grew from 2017 to a high in 2022, then eased. The most recent 18–24 months of data are subject to publication lag and will undercount actual activity.
Cilag GmbH International stands out with a ▲ +116% trend in recent filings versus the prior period—by far the highest among major applicants. Most other leading filers, including Intuitive Surgical Operations Inc (▼ -30%) and CMR Surgical Ltd (▼ -48%), show declining recent momentum consistent with the field-wide post-peak pattern.
Ready to map your own surgical robotics landscape?
Join 18,000+ innovators using PatSnap Eureka to map any technology landscape: search 2B+ patents and papers, surface key assignees, and generate a report like this in minutes.
Disclaimer. This page is generated from PatSnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. PatSnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.